Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia Q Li, X Guan, P Wu, X Wang, L Zhou, Y Tong, R Ren, KSM Leung, ... New England journal of medicine 382 (13), 1199-1207, 2020 | 22096 | 2020 |
Temporal dynamics in viral shedding and transmissibility of COVID-19 X He, EHY Lau, P Wu, X Deng, J Wang, X Hao, YC Lau, JY Wong, Y Guan, ... Nature medicine 26 (5), 672-675, 2020 | 5503 | 2020 |
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong DC Adam, P Wu, JY Wong, EHY Lau, TK Tsang, S Cauchemez, ... Nature Medicine 26 (11), 1714-1719, 2020 | 770 | 2020 |
Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020 P Wu, X Hao, EHY Lau, JY Wong, KSM Leung, JT Wu, BJ Cowling, ... Eurosurveillance 25 (3), 2000044, 2020 | 715 | 2020 |
Using social media for actionable disease surveillance and outbreak management: a systematic literature review LE Charles-Smith, TL Reynolds, MA Cameron, M Conway, EHY Lau, ... PloS one 10 (10), e0139701, 2015 | 390 | 2015 |
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases BJ Cowling, L Jin, EHY Lau, Q Liao, P Wu, H Jiang, TK Tsang, J Zheng, ... The Lancet 382 (9887), 129-137, 2013 | 386 | 2013 |
Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions ST Ali, L Wang, EHY Lau, XK Xu, Z Du, Y Wu, GM Leung, BJ Cowling Science 369 (6507), 1106-1109, 2020 | 384 | 2020 |
Neutralizing antibody titres in SARS-CoV-2 infections EHY Lau, OTY Tsang, DSC Hui, MYW Kwan, W Chan, SS Chiu, RLW Ko, ... Nature communications 12 (1), 63, 2021 | 379 | 2021 |
Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study H Yu, JT Wu, BJ Cowling, Q Liao, VJ Fang, S Zhou, P Wu, H Zhou, ... The Lancet 383 (9916), 541-548, 2014 | 369 | 2014 |
Viral shedding and clinical illness in naturally acquired influenza virus infections LLH Lau, BJ Cowling, VJ Fang, KH Chan, EHY Lau, M Lipsitch, ... The Journal of infectious diseases 201 (10), 1509-1516, 2010 | 363 | 2010 |
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA. 1 following homologous and heterologous CoronaVac or BNT162b2 vaccination SMS Cheng, CKP Mok, YWY Leung, SS Ng, KCK Chan, FW Ko, C Chen, ... Nature medicine 28 (3), 486-489, 2022 | 358 | 2022 |
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study ME McMenamin, J Nealon, Y Lin, JY Wong, JK Cheung, EHY Lau, P Wu, ... The Lancet Infectious Diseases 22 (10), 1435-1443, 2022 | 353 | 2022 |
Human infection with avian influenza A H7N9 virus: an assessment of clinical severity H Yu, BJ Cowling, L Feng, EHY Lau, Q Liao, TK Tsang, Z Peng, P Wu, ... The Lancet 382 (9887), 138-145, 2013 | 313 | 2013 |
School closure and mitigation of pandemic (H1N1) 2009, Hong Kong JT Wu, BJ Cowling, EHY Lau, DKM Ip, LM Ho, T Tsang, SK Chuang, ... Emerging infectious diseases 16 (3), 538, 2010 | 287 | 2010 |
MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015 PG Choe, R Perera, WB Park, KH Song, JH Bang, ES Kim, HB Kim, ... Emerging infectious diseases 23 (7), 1079, 2017 | 276 | 2017 |
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory … CKH Wong, ICH Au, KTK Lau, EHY Lau, BJ Cowling, GM Leung The Lancet 400 (10359), 1213-1222, 2022 | 265 | 2022 |
Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study TK Tsang, P Wu, Y Lin, EHY Lau, GM Leung, BJ Cowling The Lancet Public Health 5 (5), e289-e296, 2020 | 261 | 2020 |
Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study L Li, Y Liu, P Wu, Z Peng, X Wang, T Chen, JYT Wong, J Yang, HS Bond, ... The Lancet Public Health 4 (9), e473-e481, 2019 | 250 | 2019 |
Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong … CKH Wong, ICH Au, KTK Lau, EHY Lau, BJ Cowling, GM Leung The Lancet Infectious Diseases 22 (12), 1681-1693, 2022 | 241 | 2022 |
Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo MCW Chan, DIT Kuok, CYH Leung, KPY Hui, SA Valkenburg, EHY Lau, ... Proceedings of the National Academy of Sciences 113 (13), 3621-3626, 2016 | 214 | 2016 |